Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Eldani C, Darrigade AS, Beylot-Barry M, Jullie ML, et al. Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as "toxic epidermal necrolysis-like". Eur J Dermatol 2022;32:805-807.
PMID: 36856394


Privacy Policy